|
<p align=justify>Ad hoc announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------------<p>biolitec expands rapidly in the US - signs important contract with largest US dental distributor<p>- biolitec signs sales contract with Sullivan-Schein Dental(TM) for more than 100 dental lasers annually - 980nm dental laser of biolitec as worlds favorite - additional US-contracts expected to be signed -<p>Jena, 08/02/2001 - biolitec AG, Jena, specialist for photodynamic therapy and medical lasers, has concluded a contract with the largest US distributor for dental products, Sullivan-Schein Dental(TM). More than 100 dental lasers are expected to be delivered annually. Sullivan-Schein Dental(TM), the American dental business of the company Henry Schein, Inc. covers more than 75% of the North American market with a sales force of 600 representatives and 70 sales and service centers. biolitec estimates the value of the finalized contract incl. accessories to exceed 1.5 million US dollar for the current fiscal year. biolitec`s dental lasers are used by dentists for all kinds of successful treatment of dental indications. This applies to cosmetic treatments as well as to medical indications. Dr. Wolfgang Neuberger, CEO of biolitec that is listed at the "Neuer Markt", considers the contract with this worldwide leading dental distributor as a key element for biolitec`s expansion strategy in the US. Sullivan-Schein Dental(TM) will advertise and promote biolitec`s 980nm diode laser in the market, substantially increasing biolitec`s brand recognition. Dave Steck, Vice President of Sullivan-Schein(TM), considers biolitec`s 980nm diode laser is one of the best dental lasers worldwide. biolitec signed an additional contract with the third largest North American distributor for dental equipment that will generate further sales volume in this area. biolitec is worlds only supplier for photodynamic therapy comprising all relevant core competences - photosensitizers, lasers and fibers. biolitec AG has two facilities in Germany and is globally present with four international subsidiaries. Contact: Agnes Hübscher, IR/PR Winzerlaer St. 2a, 07745 Jena, Tel.: 03641/508554, fax: 03641/508599, mail: ir@biolitec.de<p> end of ad hoc announcement (c) DGAP 02.08.2001 -------------------------------------------------------------------------------- WKN: 521340; Index: Listed: Neuer Markt in Frankfurt; Freiverkehr in Berlin, Bremen Düsseldorf, Hamburg, Hannover, München und Stuttgart<p> 020826 Aug 01<p><br><br>Autor: DGAP import (),08:28 02.08.2001</p> |
|
| aus der Diskussion: | DGAP-Ad hoc: biolitec AG <DE0005213409> english = |
| Autor (Datum des Eintrages): | ad_hoc (02.08.01 08:28:10) |
| Beitrag: | 1 von 1 (ID:4108787) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |